about
Successful oral desensitization with crizotinib after crizotinib-induced hepatitis in an anaplastic lymphoma kinase-rearranged non-small-cell lung cancer patient: A case report.Retrospective analysis of acute exacerbation of interstitial lung diseases with nanoparticle albumin-bound paclitaxel in patients with advanced lung cancer with preexisting interstitial lung disease.Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib.PD-L1 Expression in Small Cell Lung CancerMCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expressionAcquired Resistance to Alectinib in ALK-Rearranged Lung Cancer Due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance ModelClinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumabYAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation
P50
Q41162171-72C6A173-DE6C-4E52-ACCB-F61E81E12274Q42376439-120A6A35-F8D0-4DE7-8311-8815CE2588FAQ47793525-6759FCF4-A365-45F1-B3AB-CD673F0F68F1Q87853823-C4A75270-8F50-4FD9-939B-C6CEA569BE9AQ90170085-E019C6C5-2774-44B0-B4C6-20584993C696Q90689872-A62BE08F-C21F-40E5-BF77-9A39D6BB8D41Q91344748-CFC5E183-CEBD-4AD3-8E7A-F8EF65E80F84Q92406899-736A1D11-E697-461C-BE30-881F1477B458
P50
description
researcher
@en
wetenschapper
@nl
name
Yuto Yasuda
@en
Yuto Yasuda
@nl
type
label
Yuto Yasuda
@en
Yuto Yasuda
@nl
prefLabel
Yuto Yasuda
@en
Yuto Yasuda
@nl
P108
P31
P496
0000-0002-5703-4119